Dr. Michael Weinstein interviews Dr. Don Lazas, co-founder and chief medical officer of ObjectiveHealth about partnering with physicians to provide the tools needed to integrate clinical trials into their practice.

ObjectiveHealth’s digital health technology can help identity patients who are at risk of developing Nonalcoholic Steatohepatitis (NASH).

Join Dr. Weinstein and Dr. Lazas as they explore new innovations in detecting and treating nonalcoholic fatty liver disease (NAFLD) and NASH, and how clinical research could benefit a GI practice and its patients.

Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC

Mixed and mastered by Hayden Margolis

Gastro Broadcast, Episode 58